![Idiopathic Hypersomnia Treatment Market is expected to grow at a CAGR of 8.7% over the forecast period 2022-2028 | Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, BIOPROJET - trendeepro Idiopathic Hypersomnia Treatment Market is expected to grow at a CAGR of 8.7% over the forecast period 2022-2028 | Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, BIOPROJET - trendeepro](https://i0.wp.com/www.medgadget.com/wp-content/uploads/2022/05/idiopathic-hypersomnia-treatment-market-scaled.jpg?ssl=1)
Idiopathic Hypersomnia Treatment Market is expected to grow at a CAGR of 8.7% over the forecast period 2022-2028 | Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, BIOPROJET - trendeepro
![Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-berkshire-hathaway.png)
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
![Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement](http://www.smarteranalyst.com/wp-content/uploads/2017/08/teva.png)